Pregnancy, Postpartum & Post-Transplant Neurologic Care

Maternal Stabilization and Neurologic Diagnosis

Pregnancy and the postpartum period do not protect against ordinary stroke, hemorrhage, infection, or seizures. They add specific risks and affect medication and procedural choices. Coordinate obstetric, anesthesia, stroke, neurosurgical, and ICU care as indicated. Stabilize maternal airway, oxygenation, circulation, glucose, and seizures while evaluating the cause. Necessary time-sensitive brain imaging should not be withheld reflexively because the patient is pregnant; select the study and precautions with the treating teams.

Record gestational or postpartum timing, blood pressure, headache pattern, focal findings, seizures, medication exposures, and relevant obstetric symptoms. A new severe headache is not automatically migraine. Consider preeclampsia or eclampsia, PRES, RCVS, CVT, dissection, ischemic stroke, hemorrhage, pituitary disease, and infection. Several can coexist, and a familiar label does not exclude a second process.

Preeclampsia, Eclampsia, and HELLP

Preeclampsia involves pregnancy-associated hypertension with relevant proteinuria or organ dysfunction under obstetric diagnostic criteria. Neurologic symptoms can include persistent headache, visual disturbance, altered consciousness, or seizures. Eclampsia is a seizure syndrome in the appropriate setting after considering other causes. It can occur postpartum, and a preceding diagnosis of severe preeclampsia is not required for every presentation.

Treat persistent severe hypertension promptly; obstetric guidance uses systolic pressure at least 160 or diastolic pressure at least 110 mm Hg as severe thresholds. Common acute agents include labetalol, hydralazine, and immediate-release oral nifedipine under the appropriate protocol. Hydralazine is therefore not absolutely prohibited simply because a patient has neurologic symptoms. Avoid excessive reductions that impair maternal and placental perfusion.

Magnesium sulfate is central to seizure treatment and prevention in eclampsia. Monitor respiratory status, reflexes, renal function, and magnesium exposure. Toxicity can cause loss of reflexes, respiratory depression, and cardiovascular instability; stop the infusion and use appropriate supportive treatment and calcium when indicated. Myasthenia gravis and substantial renal dysfunction create particular hazards and require specialist adaptation. Persistent seizures still need urgent airway and neurologic treatment, not indefinite reliance on magnesium alone.

HELLP denotes hemolysis, elevated liver enzymes, and low platelets. Assess for bleeding, liver complications, renal injury, and TMA alternatives such as TTP or complement-mediated disease. Delivery and obstetric treatment decisions depend on the maternal-fetal situation; the neurocritical care role is stabilization and recognition of complications while that plan is developed.

PRES, RCVS, and Venous Thrombosis

Treat blood pressure and seizures in PRES and address the trigger. In RCVS, review vasoactive exposures, recognize possible ischemic or hemorrhagic complications, and avoid assuming that every arterial narrowing requires corticosteroids for vasculitis. In CVT, pregnancy affects anticoagulant selection, but a hemorrhagic venous infarct does not automatically exclude anticoagulation.

Post-Organ-Transplant Encephalopathy

The outline also names post-transplant patients because immunosuppression changes both the infectious differential and drug handling. Evaluate the transplanted organ, time since transplant, induction and maintenance drugs, prophylaxis, recent rejection treatment, renal or hepatic function, and exposures. Fever and CSF inflammation may be muted. Infection, medication toxicity, stroke, seizures, graft dysfunction, and metabolic disturbance can coexist.

Calcineurin inhibitors such as tacrolimus or cyclosporine can be associated with tremor, encephalopathy, seizures, and PRES. A concentration in the nominal therapeutic range does not entirely exclude toxicity. Review interactions, including anti-infective drugs that alter metabolism, and assess blood pressure, magnesium, renal function, and the examination. Drug changes must be coordinated with the transplant team because abrupt unsupervised withdrawal can endanger the graft.

Host-Specific Infection and Vascular Risk

Opportunistic CNS infection depends on the immune defect and timing. Consider bacterial, viral, fungal, or parasitic causes based on host and exposure rather than applying one generic empirical regimen to every transplant recipient. MRI, blood studies, EEG, and CSF when safe can help; a negative initial study may not settle the diagnosis. Begin appropriate empirical therapy promptly when serious infection is plausible and reassess as results arrive.

Vascular events can result from embolism, coagulopathy, infection-related aneurysm, TMA, or ordinary vascular risk. A new focal deficit should activate a stroke and hemorrhage evaluation rather than be attributed automatically to immunosuppressant toxicity. When biopsy, lumbar puncture, or invasive monitoring is considered, assess hemostasis and procedural risks with the responsible specialists.

In a typical combined decision problem, a postpartum patient with seizures and severe hypertension needs immediate stabilization and an obstetric-neurologic assessment. A transplant recipient with similar MRI edema needs a different trigger search, including drug effects and infection. The imaging label PRES is a starting point for cause-directed care, not the complete diagnosis.

Sources checked October 17, 2026: ACOG preeclampsia guidance, ACOG magnesium teaching, and IDSA CNS infection guidance.